Skip to search formSkip to main contentSkip to account menu

SM 9018

Known as: SM-9018 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

perospirone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018and its metabolite, in rat brain
Summary. In vivo occupation of dopamine D1, D2 and serotonin (5-HT)2A receptors by a novel antipsychotic drug, SM-9018… 
1997
1997
Effects of Perospirone (SM-9018), a Potential Atypical Neuroleptic, on Dopamine D1 Receptor-Mediated Vacuous Chewing Movement in Rats: A Role of 5-HT2 Receptor Blocking Activity
1997
1997
塩酸 Perospirone (SM-9018) の第I相臨床試験
1996
1996
Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
1995
1995
Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats
1995
1995
Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.
Review
1995
Review
1995
[Recent progress in development of psychotropic drugs (2)--antipsychotics].
The discovery of chlorpromazine led to rapid progress in drug therapy for schizophrenia. However, conventional neuroleptics… 
1993
1993
Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats.
The effects of SM-9018, a potential atypical neuroleptic, on monoamine metabolism were studied in rats. SM-9018 dose-dependently… 
1993
1993
14C-Labeling of a Succinimide Derivative SM-9018, a Novel Antipsychotic Drug.
Highly Cited
1990
Highly Cited
1990
Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
Pharmacological studies were undertaken to clarify the profile of cis-2-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) butyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)